Your Cart is Empty
LDN 2025 Schedule
Friday
| 8:00 |
Expo Opens
|
|
|
8:30
|
Registration
|
|
|
9:00
|
Sebastian Denison, RPh
|
LDN History, Pharmacology & Mechanism of Action |
|
10
|
Sarah Zielsdorf, MD, MS, ABIM, IFMCP
|
Sex Differences in Opioid Receptor Mediated Effects: Clinical Considerations for LDN Use
|
|
10.30
|
Yoon Hang Kim MD
|
Optimal Health Through LDN
|
| 11 |
Break
|
|
|
11.30
|
Sarah Zielsdorf, MD, MS, ABIM, IFMCP
|
Ultra Low Dose Naltrexone and Opioids: Misunderstood by Pain Management |
| 12 |
Q&A
|
Q&A Panel with Clinical Pharmacist Sebastian Denison, and Drs Sarah Zielsdorf, Yoon Hang Kim and Harpal Bains |
|
1:00
|
Lunch
|
|
|
2:00
|
Michael McNeal CHHC
|
Low Dose Naltrexone in Mold Illness & CIRS - Part 1
|
|
3
|
Break
|
|
| 3.30 |
Michael McNeal CHHC |
Low Dose Naltrexone in Mold Illness & CIRS - Part 2 |
| 4.30 |
Q&A
|
Q&A - with Dr Sarah Zielsdorf, Michael McNeal CHHC, Yoon Hang Kim and Clinical Pharmacist Sebastian Denison |
|
5.30
|
End of Presentations
|
|
|
6:30
|
Expo Closes
|
Saturday
| 8:00 |
Expo Opens
|
|
|
8:30
|
Registration
|
|
|
9:00
|
Stefanie Werner, NMD
|
Psoriatic Arthritis: How LDN Changed the Course of a Life
|
|
9.30
|
Prof Angus Dalgleish
|
Why does LDN have such broad clinical benefits? |
|
10
|
Sarah Zielsdorf, MD, MS, ABIM, IFMCP
|
Autoimmune-Mediated Small-Fiber Neuropathy and Related Conditions
|
|
10.30
|
Mark Cooper PhD
|
Vitamin D Resistance - Part 1
|
|
11
|
Break
|
|
|
11:30
|
Mark Cooper PhD
|
Vitamin D Resistance - Part 2
|
|
12
|
Q&A | Q&A with Sebastian Denison, Rph, Stefanie Werner, NMD, Sarah Zielsdorf, MD, MS, ABIM, IFMCP, Mark Cooper PhD |
|
1
|
Lunch
|
|
|
2
|
Michael McNeal CHHC |
From Untreatable to Unstoppable: How to treat MCAS, EDS, & POTS |
|
3
|
Break
|
|
|
3.30
|
Understanding Stealth Syndromes - The Documentary Screening | |
|
4.30
|
Q&A
|
Q&A - with Dr Harpal Bains, Michael McNeal CHHC, Dr Mark Cooper and Clinical Pharmacist Sebastian Denison
|
|
5.3
|
|
End of Presentations |
|
6
|
|
Networking Party Starts around Exhibitors - Pay Bar Opens |
|
6.3
|
Appetizers
|
|
|
8
|
|
Networking Party Ends |
Sunday
| 8:00 |
Expo Opens
|
|
|
8:30
|
Registration
|
|
|
9:00
|
Galyn Forster MS, LPC
|
LDN moderates the neurological effects of childhood adversity |
|
9.30
|
Galyn Forster MS, LPC
|
An introduction to how naltrexone and LDN can positively alter the balance between habit-driven (addiction-like) behavior in favor of prioritizing reward-driven behavior. |
|
10
|
Chris Kleronomos, FNP-BC (AAPM), DAOM-LAc, RH (AHG), MSc (ABAAHP)
|
LDN and complex central pain: mechanisms and treatment strategies
|
|
10.30
|
Break
|
|
|
11
|
Harpal Bains, MD
|
Rewriting the Immune Script: Synergistic Potential of Low Dose Naltrexone and GLP-1 Agonists |
|
11:30
|
Q&A | Q&A - with Harpal Bains, MD, Galyn Forster MS, LPC, Chris Kleronomos, FNP-BC and Clinical Pharmacist Sebastian Denison |
|
12:30
|
Lunch
|
|
|
2
|
Conference Closes
|